1. Home
  2. OCUL vs CMPO Comparison

OCUL vs CMPO Comparison

Compare OCUL & CMPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • CMPO
  • Stock Information
  • Founded
  • OCUL 2006
  • CMPO 2000
  • Country
  • OCUL United States
  • CMPO United States
  • Employees
  • OCUL N/A
  • CMPO N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • CMPO Finance: Consumer Services
  • Sector
  • OCUL Health Care
  • CMPO Finance
  • Exchange
  • OCUL Nasdaq
  • CMPO Nasdaq
  • Market Cap
  • OCUL 1.2B
  • CMPO 1.2B
  • IPO Year
  • OCUL 2014
  • CMPO N/A
  • Fundamental
  • Price
  • OCUL $7.27
  • CMPO $10.95
  • Analyst Decision
  • OCUL Strong Buy
  • CMPO Strong Buy
  • Analyst Count
  • OCUL 9
  • CMPO 8
  • Target Price
  • OCUL $16.22
  • CMPO $16.19
  • AVG Volume (30 Days)
  • OCUL 1.8M
  • CMPO 1.2M
  • Earning Date
  • OCUL 03-03-2025
  • CMPO 03-05-2025
  • Dividend Yield
  • OCUL N/A
  • CMPO 2.28%
  • EPS Growth
  • OCUL N/A
  • CMPO N/A
  • EPS
  • OCUL N/A
  • CMPO N/A
  • Revenue
  • OCUL $63,723,000.00
  • CMPO $420,571,000.00
  • Revenue This Year
  • OCUL $14.02
  • CMPO $8.91
  • Revenue Next Year
  • OCUL $15.47
  • CMPO $8.74
  • P/E Ratio
  • OCUL N/A
  • CMPO N/A
  • Revenue Growth
  • OCUL 9.03
  • CMPO 7.67
  • 52 Week Low
  • OCUL $4.06
  • CMPO $4.97
  • 52 Week High
  • OCUL $11.78
  • CMPO $14.71
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 45.35
  • CMPO 40.20
  • Support Level
  • OCUL $7.36
  • CMPO $11.02
  • Resistance Level
  • OCUL $8.04
  • CMPO $11.91
  • Average True Range (ATR)
  • OCUL 0.45
  • CMPO 0.42
  • MACD
  • OCUL -0.02
  • CMPO 0.04
  • Stochastic Oscillator
  • OCUL 13.61
  • CMPO 38.54

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About CMPO CompoSecure Inc.

CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.

Share on Social Networks: